John A. Flygare

In vivo bioluminescence imaging of labile iron in xenograft models and liver using FeAL-1, an iron-activatable form of D-luciferin.

Allegra T. Aron, A. Renslo, Cedric L. Hugelshofer, 2023, Cell chemical biology.

Dogs are more sensitive to antagonists of inhibitor of apoptosis proteins than rats and humans: a translational toxicokinetic/toxicodynamic analysis.

P. LoRusso, W. Fairbrother, H. Wong, 2012, Toxicological sciences : an official journal of the Society of Toxicology.

Discovery of A-1331852, a First-in-Class, Potent, and Orally-Bioavailable BCL-XL Inhibitor

Xiaohong Song, Z. Tao, P. Kovar, 2020, ACS medicinal chemistry letters.

Discovery and Evaluation of TLR-Targeted Immune Agonists.

A. Willingham, W. M. Seganish, Saraswathi Naravula, 2024, Journal of medicinal chemistry.

Design and Optimization of Selectivity-Tunable Toll-like Receptor 7/8 Agonists as Novel Antibody-Drug Conjugate Payloads.

A. Willingham, W. M. Seganish, Saraswathi Naravula, 2024, Journal of medicinal chemistry.